Comparing Generic Drug Markets in Europe and the United States: Prices, Volumes, and Spending

ConclusionsGovernments should apply coherent supply‐ and demand‐side policies in generic drug markets. An immediate priority is to convince more physicians, pharmacists, and patients that generic drugs are bioequivalent to branded products. Special‐interest groups continue to obstruct reform in Europe and the United States.

Source: The Milbank Quarterly - September 12, 2017 Category: Health Management Authors: OLIVIER J. WOUTERS, PANOS G. KANAVOS, MARTIN McKEE Tags: Original Investigation Source Type: research